PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, British Columbia. The company went IPO on 2020-10-09. The firm develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The firm is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases. The firm is in the development of programs for the delivery of KETARX (ketamine) in a patch and on-body pump for mental health, pain and medical countermeasures indications.
What is the price performance of PharmaTher Holdings Ltd. stock?
The current price of PharmaTher Holdings Ltd. is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for PharmaTher Holdings Ltd.?
PharmaTher Holdings Ltd. belongs to N/A industry and the sector is N/A
What is PharmaTher Holdings Ltd. market cap?
PharmaTher Holdings Ltd.'s current market cap is $NaN
Is PharmaTher Holdings Ltd. a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for PharmaTher Holdings Ltd., including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell